Stockscreener 앱 받기
37.58
1.54%
0.57
시장 영업 전:
37.37
-0.21
-0.56%
Royalty Pharma Plc 주식(RPRX)의 최신 뉴스
CenterBook Partners LP Sells 41,728 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma raises 2025 portfolio receipts guidance to $3.05B-$3.15B as integrated company advances biotech funding model - MSN
Royalty Pharma (NASDAQ:RPRX) Upgraded at Wall Street Zen - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Stock Position Lifted by Koss Olinger Consulting LLC - MarketBeat
Cary Street Partners Financial LLC Invests $610,000 in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Did Rising Costs and Lower Margins Just Shift Royalty Pharma's (RPRX) Investment Narrative? - simplywall.st
Royalty Pharma: Keep Delivering, Buy Confirmed (NASDAQ:RPRX) - Seeking Alpha
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighWhat's Next? - MarketBeat
Royalty Pharma’s Earnings Call Highlights Strong Growth and Strategic Moves - TipRanks
More Players, Better Pricing, Tough Equity Market: Royalty Deals Go Mainstream - insights.citeline.com
UBS Adjusts Price Target on Royalty Pharma to $37 From $36, Maintains Neutral Rating - MarketScreener
Royalty Pharma plc (NASDAQ:RPRX) Q2 2025 Earnings Call Transcript - Insider Monkey
PTC Therapeutics Earnings Preview: Analysts Expect $-1.07 EPS, Historical Performance and Stock Performance - AInvest
Royalty Pharma Reports Strong Q2 2025 Results - TipRanks
Royalty Pharma (RPRX) Q2 Receipts Up 20% - AOL.com
Royalty Pharma Plc Q2 Income Retreats - Nasdaq
Royalty Pharma Raises 2025 Portfolio Receipts Guidance to $3.05B-$3.15B, Achieving 20% Growth in Top Line - AInvest
Royalty Management Holding Corporation shares rise 5.65% intraday after Royalty Pharma plc reports Q2 2025 results. - AInvest
Royalty Pharma stock price target raised to $48 from $42 at BofA Securities - Investing.com UK
Royalty Pharma Q2 2025 Earnings Call Transcript - MarketBeat
Royalty Pharma (RPRX) PT Raised to $48 at BofA Securities - StreetInsider
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates - sharewise.com
Royalty Pharma earnings missed by $0.99, revenue fell short of estimates - Investing.com Nigeria
Earnings call transcript: Royalty Pharma Q2 2025 shows robust growth By Investing.com - Investing.com Nigeria
Royalty Pharma plc SEC 10-Q Report - TradingView
Earnings call transcript: Royalty Pharma Q2 2025 shows robust growth - Investing.com
Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q2 Earnings - Yahoo Finance
Transcript : Royalty Pharma plc, Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Royalty Pharma reports second quarter 2025 results - MarketScreener
Royalty Pharma Q2 2025 slides: Double-digit growth and raised guidance - Investing.com Nigeria
Royalty Pharma Q2 Net Income Falls, Revenue Rises - MarketScreener
Royalty Pharma Reports Second Quarter 2025 Results - TradingView
Earnings Flash (RPRX) Royalty Pharma plc Reports Q2 Revenue $579.0M - MarketScreener
53,119 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by XTX Topco Ltd - MarketBeat
Mackenzie Financial Corp Purchases 205,356 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
TD Asset Management Inc Buys 27,718 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma stock hits 52-week high at 37.91 USD - Investing.com
Royalty Pharma stock hits 52-week high at 37.91 USD By Investing.com - Investing.com Canada
Countdown to Royalty Pharma (RPRX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Royalty Pharma (RPRX) Expected to Announce Earnings on Wednesday - MarketBeat
Torray Investment Partners LLC Boosts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
What are Royalty Pharma plc company’s key revenue driversIdentify safe investments with exceptional yields - Jammu Links News
What drives Royalty Pharma plc stock priceGet timely alerts on top market movers - Jammu Links News
What analysts say about Royalty Pharma plc stockDiscover breakthrough stocks with expert help - Jammu Links News
Should I hold or sell Royalty Pharma plc stock in 2025Build wealth faster with consistent investment plans - Jammu Links News
What markets is GCLWW expanding into Is Royalty Pharma plc stock a good long term investment option - Jammu Links News
What are analysts’ price targets for Royalty Pharma plc in the next 12 monthsUnmatched market gains - Jammu Links News
When is Royalty Pharma plc stock expected to show significant growthBuild a winning investment strategy today - Jammu Links News
What makes Royalty Pharma plc stock price move sharplyAchieve consistent high returns with low risk - Jammu Links News
Is Royalty Pharma plc stock overvalued or undervaluedGet timely alerts on top market movers - Jammu Links News
HB Wealth Management LLC Makes New $392,000 Investment in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
What catalysts could drive Royalty Pharma plc stock higher in 2025Get timely alerts on market opportunities - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):